FitLife Brands (FTLF) Competitors $12.10 -0.51 (-4.04%) Closing price 03/31/2025 04:00 PM EasternExtended Trading$11.58 -0.53 (-4.34%) As of 03/31/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. RLAY, CGEM, MNMD, PGEN, PHAT, KROS, AUTL, VERV, ZVRA, and CRMDShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Relay Therapeutics (RLAY), Cullinan Therapeutics (CGEM), Mind Medicine (MindMed) (MNMD), Precigen (PGEN), Phathom Pharmaceuticals (PHAT), Keros Therapeutics (KROS), Autolus Therapeutics (AUTL), Verve Therapeutics (VERV), Zevra Therapeutics (ZVRA), and CorMedix (CRMD). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Relay Therapeutics Cullinan Therapeutics Mind Medicine (MindMed) Precigen Phathom Pharmaceuticals Keros Therapeutics Autolus Therapeutics Verve Therapeutics Zevra Therapeutics CorMedix Relay Therapeutics (NASDAQ:RLAY) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings. Which has stronger earnings & valuation, RLAY or FTLF? FitLife Brands has higher revenue and earnings than Relay Therapeutics. Relay Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRelay Therapeutics$10.01M44.38-$341.97M-$2.39-1.10FitLife Brands$62.76M1.78$5.30M$0.8414.40 Which has more risk & volatility, RLAY or FTLF? Relay Therapeutics has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Does the media prefer RLAY or FTLF? In the previous week, FitLife Brands had 5 more articles in the media than Relay Therapeutics. MarketBeat recorded 16 mentions for FitLife Brands and 11 mentions for Relay Therapeutics. Relay Therapeutics' average media sentiment score of 0.55 beat FitLife Brands' score of 0.28 indicating that Relay Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Relay Therapeutics 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive FitLife Brands 3 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend RLAY or FTLF? Relay Therapeutics currently has a consensus price target of $19.80, suggesting a potential upside of 655.73%. FitLife Brands has a consensus price target of $20.50, suggesting a potential upside of 69.42%. Given Relay Therapeutics' higher probable upside, equities research analysts clearly believe Relay Therapeutics is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Relay Therapeutics 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is RLAY or FTLF more profitable? FitLife Brands has a net margin of 13.38% compared to Relay Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Relay Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Relay TherapeuticsN/A -45.75% -40.75% FitLife Brands 13.38%28.03%15.13% Does the MarketBeat Community favor RLAY or FTLF? Relay Therapeutics received 59 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 70.45% of users gave Relay Therapeutics an outperform vote while only 60.00% of users gave FitLife Brands an outperform vote. CompanyUnderperformOutperformRelay TherapeuticsOutperform Votes6270.45% Underperform Votes2629.55% FitLife BrandsOutperform Votes360.00% Underperform Votes240.00% Do institutionals and insiders hold more shares of RLAY or FTLF? 97.0% of Relay Therapeutics shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 4.3% of Relay Therapeutics shares are owned by insiders. Comparatively, 61.3% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryFitLife Brands beats Relay Therapeutics on 11 of the 19 factors compared between the two stocks. Remove Ads Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$111.44M$1.14B$5.63B$7.79BDividend YieldN/AN/A5.37%4.04%P/E Ratio14.329.3123.6118.68Price / Sales1.785.66373.3989.80Price / Cash19.0510.4038.1734.64Price / Book3.981.176.734.12Net Income$5.30M-$54.34M$3.20B$247.10M7 Day Performance-9.36%-5.80%-5.33%-3.82%1 Month Performance-19.39%-16.94%-0.40%-6.61%1 Year Performance-1.22%-41.86%7.89%-1.67% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.4964 of 5 stars$12.10-4.0%$20.50+69.4%+1.6%$111.44M$62.76M14.3220Earnings ReportShort Interest ↓Analyst RevisionHigh Trading VolumeRLAYRelay Therapeutics2.1904 of 5 stars$2.62-3.7%$19.80+655.7%-68.4%$444.15M$10.01M-1.00330News CoverageCGEMCullinan Therapeutics2.1256 of 5 stars$7.57-5.6%$32.86+334.0%-55.6%$442.94MN/A-2.6730Positive NewsMNMDMind Medicine (MindMed)2.1861 of 5 stars$5.85-5.5%$25.11+329.2%-37.8%$440.90MN/A-2.5940Gap DownPGENPrecigen3.5645 of 5 stars$1.49-6.3%$7.00+369.8%+2.8%$438.12M$3.93M-2.71190Gap UpPHATPhathom Pharmaceuticals3.2905 of 5 stars$6.27-5.0%$22.17+253.5%-41.0%$436.62M$55.25M-1.10110KROSKeros Therapeutics3.5098 of 5 stars$10.19-5.6%$42.33+315.4%-84.6%$413.33M$3.55M-1.96100News CoverageGap DownHigh Trading VolumeAUTLAutolus Therapeutics3.0281 of 5 stars$1.55-6.6%$9.52+514.2%-75.7%$412.45M$10.12M-1.28330Positive NewsGap DownVERVVerve Therapeutics1.7945 of 5 stars$4.57-12.5%$25.50+458.0%-65.6%$405.80M$32.33M-1.86110Gap DownZVRAZevra Therapeutics2.9815 of 5 stars$7.49-4.6%$22.29+197.5%+29.1%$405.33M$23.61M-3.8020Positive NewsCRMDCorMedix2.6034 of 5 stars$6.16-8.6%$15.14+145.8%+45.3%$401.52M$43.47M-7.6030Earnings ReportGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Relay Therapeutics Competitors Cullinan Therapeutics Competitors Mind Medicine (MindMed) Competitors Precigen Competitors Phathom Pharmaceuticals Competitors Keros Therapeutics Competitors Autolus Therapeutics Competitors Verve Therapeutics Competitors Zevra Therapeutics Competitors CorMedix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.